###begin article-title 0
###xml 56 60 <span type="species:ncbi:10090">Mice</span>
Heme Oxygenase-1 Accelerates Cutaneous Wound Healing in Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: AGP JD AJ. Performed the experiments: AGP RL JM KS MG PS MD AJR AZ JW HW JK. Analyzed the data: AGP RL JM KS MG PS MD AJR AZ JW HW JK AJ. Contributed reagents/materials/analysis tools: MK JD KK CK YH JD AJ. Wrote the paper: AGP JD AJ.
###end p 1
###begin p 2
###xml 267 269 267 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 275 277 275 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 624 639 <span type="species:ncbi:10090">transgenic mice</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
###xml 1255 1259 <span type="species:ncbi:10090">mice</span>
Heme oxygenase-1 (HO-1), a cytoprotective, pro-angiogenic and anti-inflammatory enzyme, is strongly induced in injured tissues. Our aim was to clarify its role in cutaneous wound healing. In wild type mice, maximal expression of HO-1 in the skin was observed on the 2nd and 3rd days after wounding. Inhibition of HO-1 by tin protoporphyrin-IX resulted in retardation of wound closure. Healing was also delayed in HO-1 deficient mice, where lack of HO-1 could lead to complete suppression of reepithelialization and to formation of extensive skin lesions, accompanied by impaired neovascularization. Experiments performed in transgenic mice bearing HO-1 under control of keratin 14 promoter showed that increased level of HO-1 in keratinocytes is enough to improve the neovascularization and hasten the closure of wounds. Importantly, induction of HO-1 in wounded skin was relatively weak and delayed in diabetic (db/db) mice, in which also angiogenesis and wound closure were impaired. In such animals local delivery of HO-1 transgene using adenoviral vectors accelerated the wound healing and increased the vascularization. In summary, induction of HO-1 is necessary for efficient wound closure and neovascularization. Impaired wound healing in diabetic mice may be associated with delayed HO-1 upregulation and can be improved by HO-1 gene transfer.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 337 340 337 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Gurtner1">[1]</xref>
The repair of wound is a complex process engaging activity of various cell types, tightly orchestrated by specific cytokines. The molecular and cellular machinery, which is switched on in response to destructive stimuli, is very similar in case of burn, cutaneous wounds, myocardial infarction, spinal-cord damage, and visceral injuries [1]. Noteworthy, chronic nonhealing wounds, leading very often to ulceration, necrosis and amputation, are one of the severe consequences of diabetes, which result in significant morbidity. Especially in this case, the new avenues for therapeutic approaches of deep skin injuries are urgently needed.
###end p 4
###begin p 5
###xml 125 128 125 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Stadelmann1">[2]</xref>
###xml 632 635 632 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Falanga1">[3]</xref>
In mammals, skin wound healing occurs in three overlapping phases: inflammation, granulation tissue formation and remodeling [2]. Briefly, the injury causes immediate blood vessel constriction and activation of coagulation cascade. When the blood clot is formed, neutrophils and monocytes enter the wound site. Then, keratinocytes and fibroblasts are stimulated to proliferate and migrate over the provisional matrix, so the granulation tissue formation begins. During the final phase of wound healing the granulation tissue is replaced with an acellular scar, when myofibroblastic and vascular cells in the wound undergo apoptosis [3].
###end p 5
###begin p 6
###xml 406 409 406 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Michaels1">[4]</xref>
###xml 493 496 493 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Bloch1">[5]</xref>
###xml 553 556 553 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Michaels1">[4]</xref>
###xml 558 561 558 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Bloch1">[5]</xref>
###xml 776 779 776 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Howdieshell1">[6]</xref>
###xml 812 819 812 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 937 940 937 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Dickens1">[7]</xref>
###xml 1074 1077 1074 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Galiano1">[8]</xref>
###xml 1232 1235 1232 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Suh1">[9]</xref>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
Vascularization of wound, achieved both by angiogenesis (formation of blood vessels from preexisting ones) and vasculogenesis (formation of blood vessels from endothelial progenitor cells), is necessary for quick and effective tissue repair. It has been shown that endostatin, an angiogenesis inhibitor, delayed wound healing through attenuation of granulation tissue formation and vascularization in mice [4], and impaired maturation of blood vessels during the restoration of skin integrity [5], although reepithelialization of wound was not affected [4], [5]. Moreover, neutralizing antibodies against vascular endothelial growth factor (VEGF), the major angiogenic and vasculogenic mediator, inhibited formation of granulation tissue and decreased number of blood vessels [6], whereas VEGF overexpression by ex vivo expanded keratinocyte cultures promoted matrix formation, angiogenesis, and healing in porcine full-thickness wounds [7]. Also diabetic wound healing was accelerated in response to VEGF via increased angiogenesis and recruiting bone marrow-derived cells [8]. Finally, transplantation of endothelial progenitor cells (EPCs) improved dermal wound healing, showing the potency of blood vessel-directed cell therapy [9].
###end p 6
###begin p 7
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Maines1">[10]</xref>
###xml 426 430 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Dulak1">[11]</xref>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Cisowski1">[14]</xref>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Suzuki1">[15]</xref>
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Sunamura1">[16]</xref>
###xml 698 702 698 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Deshane1">[17]</xref>
###xml 693 697 <span type="species:ncbi:10090">mice</span>
One of the important molecular mediators of new blood vessel formation is heme oxygenase-1 (HO-1). This cytoprotective enzyme, strongly induced by pro-oxidants and inflammatory agents, degrades heme to three compounds: CO, free iron and biliverdin, which is subsequently reduced to bilirubin by biliverdin reductase [10]. Previous studies have revealed the significance of HO-1 in regulation of synthesis and activity of VEGF [11]-[14] and its role in angiogenesis [15], [16]. Recently we have indicated an importance of HO-1 in stromal cell derived factor-1 (SDF-1)-dependent neovascularization, showing delayed wound closure and poor vascularity of wounded skin in 3-month old HO-1 knockout mice [17].
###end p 7
###begin p 8
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Hanselmann1">[18]</xref>
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Kampfer1">[19]</xref>
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Platt1">[20]</xref>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
It has been shown that HO-1 is rapidly induced in the wounded tissues [18], [19]. Keeping in mind its pro-angiogenic, anti-inflammatory and cytoprotective properties, as well as its influence on cell proliferation and migration [20], one can suppose that expression of HO-1 may play a role in the process of wound healing. The aim of our study was to verify this hypothesis. We evidenced the significance of HO-1 in skin repair, and demonstrated that delayed HO-1 induction may contribute to the impairment of wound healing in diabetes. Accordingly, we showed that HO-1 gene transfer may facilitate wound closure and neovascularization in diabetic mice.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
Effect of SnPPIX on wound closure
###end title 10
###begin p 11
###xml 33 41 33 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 309 318 305 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g001">Fig. 1A,B</xref>
###xml 45 50 <span type="species:ncbi:9606">human</span>
First experiments were performed in vitro on human keratinocyte cell line HaCaT, using a scratch assay model. Incubation of cells with tin protoporphyrin (SnPPIX, a competitive inhibitor of heme oxygenases, 10 micromol/mL) significantly slowed down the closure of gap created on the confluent cell monolayer (Fig. 1A,B). Most likely this resulted from reduction of keratinocyte migration, not proliferation, as all experiments were performed in the presence of 10 mM hydroxyurea, a cell cycle blocker.
###end p 11
###begin title 12
###xml 80 88 76 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Effect of SnPPIX (10 micromol/L) on time of gap closure by HaCaT cells cultured in vitro in the presence of hydroxyurea (10 mmol/L).
###end title 12
###begin p 13
Scratch assay. A - Quantitative data. Each point represents mean+/-SD of 3 experiments done in duplicates. * P<0.05 in comparison to control. B - representative pictures. Scale bar = 200 microm.
###end p 13
###begin p 14
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 412 419 412 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g002">Fig. 2A</xref>
###xml 552 554 552 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 557 559 557 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 566 568 566 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Then we investigated the wound healing process in vivo, in 3-month old C57BL wild type mice. Two circular wounds (4 mm in diameter) on the dorsum of each animal were created using biopsy punch. In the first step we checked the effect of wounding on HO-1 expression. By means of western-blotting we investigated the level of HO-1 protein in the tissue lysates prepared from healthy and wounded skins. As shown in Fig. 2A, expression of HO-1 in the healthy tissue was relatively low. Upon injury it was rapidly upregulated and remained very high on day 1st, 2nd, and 3rd, then gradually decreased.
###end p 14
###begin title 15
A - Expression of HO-1 protein in healthy and wounded skin.
###end title 15
###begin p 16
###xml 695 697 683 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 703 705 691 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
H - healthy skin, PC - positive control (HaCaT cells stimulated with 10 micromol/L of hemin for 24 h). Western blot analysis. Tubulin was used as a housekeeping gene to control the protein loading. One of 3 similar blots. B - Effect of SnPPIX (45 micromol/kg of body weight) injected subcutaneously (once a day for 10 days) on wound closure in C57BL mice. C - Effect of SnPPIX (45 micromol/kg of body weight), injected intraperitoneally (once a day for 10 days) on wound closure in C57BL mice. Each bar represents mean+SD; N = 10 animals per group. * P<0.05, ** P<0.01 in comparison to control, vehicle injected animals. D - representative pictures taken immediately after wounding, and on the 3rd and 7th days. Scale bar = 1 mm.
###end p 16
###begin p 17
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.p.</italic>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s.c.</italic>
###xml 395 399 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s.c.</italic>
###xml 566 568 566 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 570 579 570 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g002">Fig. 2B,D</xref>
###xml 647 649 647 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 733 735 733 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 748 752 748 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.p.</italic>
###xml 816 818 816 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 991 995 991 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s.c.</italic>
###xml 1064 1073 1064 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g002">Fig. 2C,D</xref>
###xml 1159 1161 1159 1161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 1226 1228 1226 1228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 1240 1244 1240 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s.c.</italic>
###xml 1249 1253 1249 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.p.</italic>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 1107 1111 <span type="species:ncbi:10090">mice</span>
###xml 1311 1315 <span type="species:ncbi:10090">mice</span>
In the second step we examined the effect of SnPPIX on wound healing. To this end, immediately after wounding, mice were divided into four groups and injected every day for 10 consecutive days either intraperitoneally (i.p.) or subcutaneously (s.c.) with SnPPIX or with vehicle. The animals were photographed every day to measure the wound surface. Analysis of images revealed that mice treated s.c. with SnPPIX showed a delayed wound closure compared to mice injected with the vehicle, which was evident throughout the whole process of healing, beginning from day 1st (Fig. 2B,D). The first fully closed wounds in control mice were found on the 7th day after wounding, whereas in SnPPIX-treated group they appeared earliest on day 8th. In case of i.p. injected animals, the delay did not become apparent until the 3rd day after injury, which might be associated with less effective penetration of the inhibitor to the wounded tissue than after local injection. However, similarly as in the s.c. treated individuals, the delayed wound healing was clearly visible (Fig. 2C,D). Again, in the vehicle injected mice the fully closed wounds appeared first on the 7th day after wounding, whereas in the SnPPIX treated group on the 8th day. Thus, s.c. and i.p. injections of SnPPIX result in impaired wound closure in mice, which may suggest that HO-1 plays a role in the process of wound healing.
###end p 17
###begin title 18
Effect of HO-1 deficiency on wound healing
###end title 18
###begin p 19
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Jozkowicz3">[21]</xref>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Grundemar1">[22]</xref>
###xml 313 316 313 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 344 347 344 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 362 365 362 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
SnPPIX is commonly used to suppress HO-1 activity in cell culture and animal experiments. However, it exerts also a variety of non-specific, HO-1 independent effects [21], [22]. Therefore, to confirm the importance of HO-1, we investigated the wound healing process in C57BLxFVB mice of normal level of HO-1 (HO-1+/+) and mice lacking one (HO-1+/-) or both (HO-1-/-) HO-1 alleles.
###end p 19
###begin p 20
###xml 48 52 48 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Deshane1">[17]</xref>
###xml 146 149 146 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 206 213 206 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g003">Fig. 3A</xref>
###xml 319 321 319 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 327 329 327 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 416 423 416 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g002">Fig. 2A</xref>
###xml 477 480 477 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 518 521 518 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 528 535 528 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g003">Fig. 3A</xref>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
As we have already noticed in the earlier paper [17], lack of HO-1 was associated with significantly delayed wound closure in the 3-month old HO-1-/- mice compared to the wild type animals of the same age (Fig. 3A). Noteworthy, the most pronounced differences were observed during the first phases of healing, between 1st and 6th day after injury, at the time of the strongest induction of HO-1 in the wounded skin (Fig. 2A). The rate of wound healing in the heterezygous (HO-1+/-) animals, was similar to that in HO-1+/+ mice (Fig. 3A).
###end p 20
###begin title 21
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
Closure of cuteneous wounds in the HO-1+/+ (WT), HO-1+/- (HT), or HO-1-/- (KO) C57BLxFVB mice.
###end title 21
###begin p 22
###xml 343 345 343 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
A - 3-month old animals. B - 6-month old animals. Each point represents individual animal (N = 4-5), lines connect the median values. Crossed points represent animals subjected to euthanasia. * P<0.05, ** P<0.01 in comparison to WT. C - representative pictures showing the wounds in 6-month old animals immediately after wounding and on day 10th. Scale bar = 5 mm.
###end p 22
###begin p 23
###xml 301 308 301 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g003">Fig. 3B</xref>
###xml 341 344 341 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 353 356 353 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 456 463 456 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g003">Fig. 3C</xref>
###xml 641 643 641 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 789 795 787 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
Effect of HO-1 deficiency on wound healing in the older, 6-month old animals, was remarkable. Time required for wound closure in the wild type mice did not differ significantly compared to the younger ones. However, lack of even one functional HO-1 allele resulted in a potent delay in wound healing (Fig. 3B). In some individuals (both HO-1+/- and HO-1-/-) wounds did not cure at all and their surface increased with time forming large unhealing lesions (Fig. 3C). Such animals had to be subjected to euthanasia before the planned end of experiment. Immunohistochemical staining of CD31-positive endothelial cells, carried out on the day 17th after injury, demonstrated that number of blood vessels was lower in nonhealing than in healing skins of HO-1 deficient individuals (9.76+/-1.64 versus 11.84+/-1.66 of vessels per surface unit, P = 0.035). Necrotic areas were also visible within the wounds. However, the mechanism behind reduced vascularization is not clear, as we did not observe any significant differences in concentration of VEGF, SDF-1 or tumor necrosis factor-alpha (TNFalpha) in the tissue lysates prepared from the healing and nonhealing wounds (data not shown).
###end p 23
###begin title 24
Effect of SnPPIX and HO-1 deficiency on production of inflammatory mediators
###end title 24
###begin p 25
###xml 233 235 233 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
Since restoration of tissue integrity and function is strongly dependent on inflammation, we compared the influence of subcutaneous injection of SnPPIX and HO-1 deficiency on a profile of cytokines in the blood serum of mice on the 3rd day post-wounding, using a protein macroarrays (RayBiotech).
###end p 25
###begin p 26
###xml 116 122 116 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005803-t001">Tab. 1</xref>
###xml 225 228 225 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 237 240 237 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 452 458 <span type="species:ncbi:10090">murine</span>
We found that SnPPIX strongly decreased concentrations of many inflammatory mediators in the blood of wounded mice (Tab. 1). Some of those effects were possibly HO-1 dependent, as similar downregulations were observed in HO-1+/- and HO-1-/- animals. Namely, the coherent results were obtained for soluble CD40 antigen (sCD40), granulocyte-macrophage colony stimulating factor (GM-CSF), interferon-gamma (IFNgamma), interleukin-2 (IL-2), IL-17, and KC (murine ortholog of IL-8). One can suppose that reduction of some of these mediators may potentially contribute to impairment of wound healing in response to pharmacological or genetic inhibition of HO-1.
###end p 26
###begin title 27
List of genes differently expressed in animals with pharmacologically or genetically inhibited HO-1, 3 days after wounding.
###end title 27
###begin p 28
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Presence of proteins in the serum of mice was analyzed using RayBiotech arrays followed by densitometric measurements. Data are shown as semiquantitative estimations of signals: + indicates OD>0.1 of value measured for positive control.
###end p 28
###begin p 29
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 71 74 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 376 379 376 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 470 473 466 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 482 485 478 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 620 623 614 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 660 663 652 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 664 668 <span type="species:ncbi:10090">mice</span>
In case of VEGF we observed decreased concentration in HO-1+/- and HO-1-/- mice, but not in animals treated with SnPPIX, where inhibition of HO-1 might be too weak. Tendency for reduced production of VEGF in HO-1 deficient mice was confirmed by ELISA performed in cell lysates prepared from the wounded skins 3 days after injury, where VEGF concentration in comparison to HO-1+/+ animals was decreased to 62.4+/-41.0% (P = 0.075) and to 74.9+/-16.2% (P = 0.071) for HO-1+/- and HO-1-/-, respectively. Interestingly, we also observed significant decrease in amount of SDF-1, which reached 44.6+/-21.9% (P = 0.005) in HO-1+/- and 35.6+/-18.0% (P = 0.002) in HO-1-/- mice, in comparison to values measured in wild type individuals.
###end p 29
###begin p 30
Finally, several effects of SnPPIX were clearly HO-1 independent, being opposite to the results of HO-1 deficiency, as demonstrated for soluble CD30T antigen, chemokine CXCL-10, IL-10, IL-12 or IL-13. Keeping in mind that both pharmacological and genetic HO-1 inhibition impairs wound healing, we suppose that those mediators are not involved in the process studied.
###end p 30
###begin title 31
Effect of skin-specific HO-1 overexpression on wound healing
###end title 31
###begin p 32
###xml 140 142 140 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg</sup>
###xml 377 385 377 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 468 475 468 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g004">Fig. 4A</xref>
###xml 547 554 547 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g004">Fig. 4B</xref>
###xml 581 588 581 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g004">Fig. 4C</xref>
###xml 119 134 <span type="species:ncbi:10090">transgenic mice</span>
###xml 152 157 <span type="species:ncbi:9606">human</span>
###xml 189 194 <span type="species:ncbi:9606">human</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
We decided to investigate whether local overexpression of HO-1 may facilitate wound healing. Therefore, we created the transgenic mice (HO-1Tg) bearing human HO-1 gene under control of the human keratin 14 promoter to overexpress HO-1 specifically in keratinocytes, in the epidermal layer of the skin. Analysis of the primary keratinocytes isolated from such mice and cultured in vitro evidenced the upregulated HO-1 expression both at mRNA level, as shown by RT-PCR (Fig. 4A), and at protein level, as visualized by immunohistochemical staining (Fig. 4B) and quantified by ELISA (Fig. 4C). Such overexpression was not observed in other cell types analyzed (data not shown).
###end p 32
###begin title 33
###xml 23 29 <span type="species:ncbi:10090">murine</span>
HO-1 overexpression in murine keratinocytes.
###end title 33
###begin p 34
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 76 78 76 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg</sup>
###xml 352 360 352 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 588 591 584 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 295 301 <span type="species:ncbi:10090">murine</span>
###xml 434 440 <span type="species:ncbi:10090">murine</span>
A - Expression of human HO-1 mRNA in the skin of HO-1+/+ and transgenic HO-1Tg mice C57BL mice. Electrophoresis of RT-PCR products (2% agarose gel). EF2 was used as a housekeeping gene. One of 4 similar analyses. B - Representative pictures of immunocytofluorescent staining for HO-1 in primary murine keratinocytes isolated from newborns and cultured in vitro. Scale bar = 100 microm. C - Concentration of HO-1 in lysates of primary murine keratinocytes isolated from newborns and cultured in vitro. ELISA. Each bar represents mean+SD of 6 measurements. *** P<0.001 in comparison to HO-1+/+.
###end p 34
###begin p 35
###xml 154 162 154 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 184 191 184 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g005">Fig. 5A</xref>
###xml 399 406 399 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g005">Fig. 5B</xref>
###xml 510 511 510 511 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 514 521 514 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g005">Fig. 5C</xref>
###xml 586 593 586 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g005">Fig. 5D</xref>
###xml 276 291 <span type="species:ncbi:10090">transgenic mice</span>
Interestingly, the augmented expression of HO-1 accelerated the closure of scratch in a monolayer of primary transgenic keratinocytes, as demonstrated by in vitro wound healing assay (Fig. 5A). This indicates that HO-1 improves migration of keratinocytes. Cells isolated from transgenic mice displayed also a tendency to increased proliferation, however this did not reach statistical significance (Fig. 5B). Finally, HO-1 overexpression improved viability of cells kept for 24 h under hypoxic conditions (1% O2) (Fig. 5C), and slightly increased production of VEGF induced by hypoxia (Fig. 5D).
###end p 35
###begin title 36
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 71 73 71 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg</sup>
###xml 96 105 96 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro.</italic>
###xml 20 26 <span type="species:ncbi:10090">murine</span>
Activity of primary murine keratinocytes isolated from HO-1+/+ and HO-1Tg newborns and cultured in vitro.
###end title 36
###begin p 37
###xml 246 247 246 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 458 461 458 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
A - Migration of cells measured by time of gap closure in the presence of hydroxyurea (10 mmol/L). Scratch assay. B - Spontaneous proliferation of cells cultured for 48 h. BrdU incorporation assay. C - Viability of cells cultured in hypoxia (1% O2) for 24 h. MTT reduction assay. D - Concentration of VEGF in media harvested from cell cultures after a 24 h incubation. Each bar represents mean+SD of 3-5 experiments. * P<0.05, ** P<0.01 in comparison to HO-1+/+.
###end p 37
###begin p 38
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 51 53 51 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg</sup>
###xml 233 235 233 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 237 244 237 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g006">Fig. 6A</xref>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Wound healing experiments performed in vivo on HO-1Tg mice showed that increased expression of HO-1 in keratinocytes is enough to accelerate significantly the wound closure throughout the whole process of healing, starting from day 1st (Fig. 6A).
###end p 38
###begin title 39
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 65 67 65 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg</sup>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
A - Closure of cutaneous wounds in the HO-1+/+ wild type and HO-1Tg mice.
###end title 39
###begin p 40
###xml 109 112 109 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 556 559 552 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
Each bar represents mean+SD. N = 10 animals per group. * P<0.05, ** P<0.01, *** P<0.001 in comparison to HO-1+/+ mice. B - Representative pictures demonstrating CD31 staining of endothelial cells in the wounded skin (3 days after wounding) in the 3-month old mice of different genotypes. Scale bar = 100 microm. C - Number of vessels in wounded skin (3 days after wounding, CD31 staining) in the 3-month old mice of different genotypes. Each bar represents analysis of samples from 5-8 animals. Data are presented as mean+SD. * P<0.05 in comparison to HO-1+/+ animals.
###end p 40
###begin title 41
Effect of HO-1 expression on vascularization of wounds
###end title 41
###begin p 42
###xml 329 332 329 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 341 344 341 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 366 369 366 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 472 474 472 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg</sup>
###xml 533 540 533 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g006">Fig. 6B</xref>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
Vascularization of wounds was assessed in 3-month old mice of different genotypes by immunohistochemical staining of endothelial cells using anti-CD31 antibodies. It turned out that density of blood vessels, measured three days after injury, reflected very well the rate of wound healing. Vascularization was the same in the HO-1+/+ and HO-1+/- mice, whereas in HO-1-/- animals the number of vessels was significantly lower. Accordingly, overexpression of HO-1 in the HO-1Tg mice was associated with strongly increased angiogenesis (Fig. 6B).
###end p 42
###begin title 43
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Expression of HO-1 during wound healing in diabetic mice
###end title 43
###begin p 44
###xml 301 308 301 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g007">Fig. 7A</xref>
###xml 400 402 400 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 191 196 <span type="species:ncbi:9606">human</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
Wound healing is impaired in diabetes. We wanted to examine the expression of HO-1 in diabetic wounds. To this end, we performed experiments in hyperglycemic db/db mice, which are a model of human type 2 diabetes. As expected, db/db mice exhibited delayed wound closure compared to wild type animals (Fig. 7A). This retardation was evident throughout the whole process of healing, starting form the 1st day. Wound closure in diabetic animals was completed 15 days after wounding, 5 days later than in their wild type counterparts.
###end p 44
###begin title 45
###xml 79 83 <span type="species:ncbi:10090">mice</span>
A - Closure of cutaneous wounds in the wild type (WT) and db/db diabetic C57BL mice.
###end title 45
###begin p 46
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
###xml 747 751 <span type="species:ncbi:10090">mice</span>
Each bar represents mean+SD; N = 10 animals per group. ** P<0.01, *** P<0.001 in comparison to WT animals. B - Number of vessels in healthy and wounded skin in the WT and db/db mice. Each bar represents analysis of samples from 10 animals. Data are presented as mean+SD. * P<0.05 in comparison to healthy skin (day 0); # P<0.05 in comparison to WT animals. C - Representative pictures showing blood vessels in healthy and wounded skin of WT and db/db mice. Immunohistochemical staining for CD31. Scale bar = 100 microm. D - Western blot analysis of HO-1 protein expression in healthy and wounded skin of the WT and db/db mice. One of 5 similar blots. E - Western blot analysis of HO-1 protein expression in healthy skin of the wild type and db/db mice 24 h after intradermal injection with hemin (10 mg/kg of body weight). One of 2 similar blots. Tubulin was used as a housekeeping gene to control the protein loading.
###end p 46
###begin p 47
###xml 300 302 300 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 395 404 395 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g007">Fig. 7B,C</xref>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
Delayed healing was associated with significantly decreased tissue vascularization. In healthy skins, numbers of vessels in the wild type and db/db mice were similar, as revealed by CD31 staining. In both cases tissue injury induced angiogenesis, and vessel density reached the highest level on the 3rd day. However, this increase was much weaker in diabetic mice compared to wild type animals (Fig. 7B,C). When wound healing process was ending, nonfunctional capillaries underwent regression and the number of vessels decreased in both groups.
###end p 47
###begin p 48
###xml 388 395 388 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g007">Fig. 7D</xref>
###xml 862 869 862 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g007">Fig. 7E</xref>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
###xml 856 860 <span type="species:ncbi:10090">mice</span>
Western blot analyses showed that expression of HO-1 was upregulated after injury both in wild type and db/db mice. However the time course of this process was different. In the wild type animals HO-1 expression reached the highest level during first three days post-wounding, whereas in db/db mice the maximal HO-1 induction was postponed, with the highest level of expression on day 8 (Fig. 7D). Thus, during the first phases of response to injury, expression of HO-1 was weaker in diabetic than in wild type animals. Such impaired induction of HO-1 we observed also after intradermal injection of hemin, a substrate and potent inducer of HO-1 expression. In wild type animals local injection of hemin resulted in a strong upregulation of HO-1 protein in the healthy skin. In contrast, the same treatment led to a very weak response in the skin of db/db mice (Fig. 7E).
###end p 48
###begin title 49
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Effect of HO-1 gene transfer on wound healing in diabetic mice
###end title 49
###begin p 50
###xml 325 333 325 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 243 246 <span type="species:ncbi:10116">rat</span>
###xml 311 314 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Because expression of HO-1 was disturbed in the wounds of diabetic mice, we investigated whether transfer of HO-1 gene into the injured tissue may improve the healing process. To address this question, we produced adenoviral vectors harboring rat HO-1 cDNA (AdHO-1) or control GFP cDNA (AdGFP) under control of CMV promoter. In vitro experiments evidenced that these carriers provided high level of transgene expressions (data not shown).
###end p 50
###begin p 51
###xml 139 140 139 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 404 406 404 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 434 441 434 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g008">Fig. 8A</xref>
###xml 851 858 851 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g008">Fig. 8B</xref>
###xml 1013 1020 1013 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g008">Fig. 8C</xref>
###xml 1202 1204 1200 1202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 2122 2124 2110 2112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 2227 2229 2215 2217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 2274 2281 2262 2269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g008">Fig. 8B</xref>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 907 910 <span type="species:ncbi:10116">rat</span>
###xml 1273 1279 <span type="species:ncbi:10090">murine</span>
###xml 1284 1287 <span type="species:ncbi:10116">rat</span>
###xml 1416 1420 <span type="species:ncbi:10090">mice</span>
Immediately after injury db/db mice were injected intradermally at four sites around the wounds either with AdGFP or AdHO-1 vectors (2.3x107 IU per wound). This treatment did not induce any noticeable side effects, as evidenced by unchanged level of aspartate aminotransferase in the blood of animals (data not shown). The presence of transduced cells in the skin was confirmed by GFP expression on the 3rd day in the injured tissue (Fig. 8A). We did not find GFP-positive cells in any other organ analyzed (liver, kidney, lungs, spleen), which indicates that transgene localized only near the site of injection. However, the level of transgene expression was low and we were unable to detect the differences in HO-1 protein concentration in tissue lysates prepared from the wounded skin of AdHO-1 and AdGFP injected animals on day 3 after injection (Fig. 8B). Importantly, RT-PCR with primers specific for rat HO-1 evidenced transgene expression at mRNA level already on day 1 and also on day 3 after injection (Fig. 8C). This was fully confirmed by quantitative, real-time RT-PCR (signal undetectable in AdGFP injected wounds; HO-1/EF2 ratio 0.014+/-0.0097 P<0.0132 for AdHO-1 treated wounds on day 1st). On the other hand, real-time RT-PCR with primers recognizing both murine and rat HO-1, indicated the tendency for increased expression of total HO-1 mRNA, but the differences between AdGFP and AdHO-1 injected mice did not reach statistical significance. Namely, HO-1 to EF2 reference gene ratio was 0.052+/-0.020 in AdGFP and 0.071+/-0.031 in AdHO-1 (P = 0.056) on day 1 and 0.054+/-0.026 in AdGFP and 0.065+/-0.009 (P = 0.230) on day 3. Possibly, transgene expression is masked by significant induction of endogenous enzyme in response to injury, as the HO-1/EF2 ratio in healthy skin was 0.013+/-0.012. It appears however, that local expression of HO-1 in the transduced cells can be upregulated. This supposition is supported by measurement of HO-1 protein at later time points, when expression of endogenous HO-1 is already diminished. Thus, although we observed similar upregulation of HO-1 expression on the 3rd day post-wounding both in AdGFP and AdHO-1 treated wounds, the higher HO-1 protein concentration on 14th day was observed in AdHO-1 injected wounds (Fig. 8B).
###end p 51
###begin title 52
Expression of GFP and HO-1 transgenes in skin.
###end title 52
###begin p 53
###xml 168 169 168 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 352 354 348 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 361 363 357 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 642 644 638 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 650 652 646 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 566 569 <span type="species:ncbi:10116">rat</span>
###xml 591 594 <span type="species:ncbi:10116">rat</span>
###xml 595 601 <span type="species:ncbi:10090">murine</span>
A - Representative pictures showing the expression of GFP in the wounded skin of db/db diabetic mice, 3 days after local injection with AdGFP adenoviral vectors (2.3x107 IU). Bright field and fluorescence microscopy. Scale bar = 100 microm. B - Concentration of HO-1 protein in tissue lysates of healthy and wounded skin of db/db mice, measure on the 3rd and 14th days after AdGFP and AdHO-1 vector delivery. Each bar represent mean+SD for 5-8 animals. # P<0.05 in comparison to healthy skin; * P<0.05 in comparison to AdGFP injected animals. C - RT-PCR analysis of rat HO-1 mRNA and total (rat/murine) mRNA in wounded skin, measured on the 1st and 3rd days after AdGFP and AdHO-1 vector delivery. Electrophoresis of RT-PCR products in 2% agarose gel. NC-negative control, HS-healthy skin.
###end p 53
###begin p 54
###xml 209 216 209 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g009">Fig. 9A</xref>
###xml 355 364 355 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g009">Fig. 9B,C</xref>
###xml 375 377 375 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 521 523 521 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
Despite the low level of transgene expression, wound closure analysis showed accelerated wound healing in AdHO-1 injected mice, visible during the earlier phases of healing, between days 1 and 7 after injury (Fig. 9A). Moreover, improved wound healing was accompanied by increased number of blood vessels within the wounds, as shown by staining for CD31 (Fig. 9B,C). On the 3rd day, much stronger vascularization was observed in AdHO-1 injected wounds than in AdGFP treated ones. The number of capillaries decreased on 14th day post-wounding. Taken together, HO-1 gene transfer may improve wound healing in db/db mice, which is associated with increased blood vessel formation.
###end p 54
###begin title 55
Effect of HO-1 transgene delivery on wounds.
###end title 55
###begin p 56
###xml 109 110 109 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 669 671 661 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 678 680 670 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
###xml 625 629 <span type="species:ncbi:10090">mice</span>
A - Effect of HO-1 transgene delivery on wound closure in the db/db diabetic mice. Adenoviral vectors (2.3x107 IU in 100 microL of PBS) were injected subcutaneously near the wound immediately after injury. Control animal were injected with the same amount of AdGFP carriers. Each bar represents mean+SD; N = 5-8 animals per group. * P<0.05 in comparison to control, AdGFP treated mice. B - representative pictures showing blood vessels in the wounded skin of db/db mice injected with AdHO-1 or AdGFP vectors. CD31 staining of the skin cross-section. Scale bar = 100 microm. C - Number of vessels in wounded skin in the db/db mice injected with AdHO-1 or AdGFP, on the 3rd and 14th days after wounding. Analysis of specimens stained for CD31 to visualize endothelial cells. Each bar represents mean+SD values for 5-8 animals. * P<0.05 in comparison to control, AdGFP injected animals.
###end p 56
###begin title 57
Discussion
###end title 57
###begin p 58
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Dulak1">[11]</xref>
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Deshane1">[17]</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Maines2">[23]</xref>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Loboda1">[24]</xref>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Loboda1">[24]</xref>
###xml 493 497 <span type="species:ncbi:10090">mice</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
HO-1 is a cytoprotective enzyme playing a role in regulation of angiogenesis and in modulation of immune response [11]-[17], [23], [24]. Its involvement in proper function of cardiovascular system, efficient neovascularization of ischemic tissues or progression of tumors is relatively well known [24]. However, significance of HO-1 in wound healing has not been established. Our study demonstrates that: i) pharmacological or genetic inhibition of HO-1 impairs healing of cutaneous wounds in mice; ii) induction of HO-1 in response to injury is impaired in diabetic mice, in which wound healing is delayed; iii) this delay may be partially reversed by HO-1 overexpression, the effect associated with increased vascularization of the wounded tissue.
###end p 58
###begin p 59
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Wagener1">[25]</xref>
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Hanselmann1">[18]</xref>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Wagener1">[25]</xref>
###xml 573 577 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Patil1">[26]</xref>
###xml 804 808 804 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Nolan1">[27]</xref>
###xml 626 634 <span type="species:ncbi:9606">patients</span>
Wounding leads to hemolysis and release of toxic free heme, which is a potent inducer of HO-1 expression, and a physiologic trigger to start inflammatory processes [25]. It has been suggested that HO-1 could be involved in the control of wound healing and might serve as a protective agent against oxidative and inflammatory insults [18], [25]. This suggestion has been supported by observation that pharmacological induction of HO-1 was associated with a significant acceleration of wound healing and attenuation of the inflammatory response in injured corneal epithelium [26]. Also a clinical analysis of sickle cell anemia patients, which showed a connection between a higher HO-1 activity, reflected by serum bilirubin, and protection against leg ulcers might suggest a role of HO-1 in wound healing [27].
###end p 59
###begin p 60
###xml 108 115 108 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g002">Fig. 2A</xref>
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Hanselmann1">[18]</xref>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Kampfer1">[19]</xref>
###xml 610 612 610 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 633 637 633 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s.c.</italic>
###xml 732 736 732 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.p.</italic>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
In our model of excisional wound, the rapid upregulation of HO-1 mRNA and protein was observed upon injury (Fig. 2A), corroborating the earlier reports [18], [19]. To elucidate the role of HO-1 induction we applied two models i) pharmacological inhibition of HO-1 using SnPPIX and ii) HO-1 deficient mice. In both cases decrease in HO-1 activity impaired wound healing. In mice injected subcutaneously with SnPPIX or in HO-1 deficient individuals, the delay was statistically significant already on the first day after wounding, while in case of intraperitoneal injections of SnPPIX it became apparent on the 3rd day. Probably after s.c. application the inhibitor was instantaneously in contact with the injured tissues while after i.p. delivery the saturation point of SnPPIX in the organism was reached later. It should be also kept in mind that SnPPIX, being a competitive inhibitor of HO-1, may in the same time induce HO-1 expression. Therefore it decreases enzymatic activity of HO-1, but usually is unable to block it completely. We suppose that this is a reason of much weaker effect of pharmacological than genetic inhibition of HO-1 on wound healing.
###end p 60
###begin p 61
###xml 130 139 130 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005803-g003">Fig. 3A,B</xref>
###xml 530 534 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Poss1">[28]</xref>
###xml 556 560 556 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Pittock1">[29]</xref>
###xml 590 594 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Poss2">[30]</xref>
###xml 806 810 806 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Poss1">[28]</xref>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
Interestingly, the effect of HO-1 deficiency increased with age and was much stronger in 6-month old than in 3-month old animals (Fig. 3A,B). Moreover, we did not observe significant delay in wound closure in younger heterozygous mice, whereas the effect of decreased level of HO-1 in older heterozygotes was strong, leading to complete inhibition of reepithelialization and formation of skin lesions in some individuals. Similar effects of aging in HO-1 deficient mice have been observed earlier in studies on endotoxemic stress [28], kidney inflammation [29], fibrosis and hepatic injury [30]. Disease symptoms typical for HO-1 deficiency, including anemia, iron-loading, lipid peroxidation, and chronic inflammation, that were not detectable at 6-9 weeks of age, became first evident by around 20 weeks [28].
###end p 61
###begin p 62
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Frank1">[31]</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Nolan1">[27]</xref>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Thomas1">[32]</xref>
###xml 78 84 <span type="species:ncbi:9606">people</span>
###xml 116 124 <span type="species:ncbi:9606">patients</span>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
Noteworthy, anemia is known to impair wound healing, as demonstrated in older people [31] or in sickle cell disease patients [27]. It is also a very frequent complication of diabetes, occurring in about 20% of patients, in whom it constitutes a significant additional burden, accompanied by systemic inflammation [32]. Increasing severity of symptoms in aging mice may suggest that effect of HO-1 deficiency on wound healing is not only direct, but may be also indirect, resulting from progressing hemolytic anemia or augmented injury of tissues caused by continues inflammatory reaction and oxidative stress.
###end p 62
###begin p 63
###xml 352 360 352 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Drukala1">[33]</xref>
###xml 742 746 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Jazwa1">[34]</xref>
###xml 903 907 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Jozkowicz2">[13]</xref>
###xml 926 930 926 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Loboda1">[24]</xref>
###xml 330 338 <span type="species:ncbi:9606">patients</span>
###xml 722 727 <span type="species:ncbi:9606">human</span>
While HO-1 inhibition impairs healing of excisional wounds, overexpression of HO-1 may facilitate this process. We demonstrated that tissue-specific upregulation of HO-1 in keratinocytes is enough to accelerate wound closure and augment vascularization. It seems important, as keratinocytes can be relatively easily isolated from patients and expanded in vitro. Such keratinocyte preparations are already used in clinic for treatment of burn injuries [33]. Our study may suggest that pharmacological HO-1 upregulation or gene delivery of HO-1 to the cultured cells could further improve their therapeutic potential. Indeed, as we have shown previously, HO-1 upregulates VEGF synthesis and angiogenic potential of cultured human keratinocytes [34]. The application of HO-1 by-products can be also considered, as both CO and biliverdin were demonstrated to upregulate VEGF production in endothelial cells [13] and keratinocytes [24], respectively.
###end p 63
###begin p 64
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-DiFilippo1">[35]</xref>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10116">rats</span>
Importantly, we found that expression of HO-1 can be reduced in diabetic animals. We observed impaired induction of HO-1 in response to hemin in the skin of db/db mice, when compared to the wild type counterparts. Western-blot analysis suggested also some delay in induction of HO-1 in wounded skin. Interestingly, the reduced response to hemin has been already observed in myocardium of diabetic rats [35].
###end p 64
###begin p 65
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Hayashi1">[36]</xref>
###xml 290 294 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Oksala1">[40]</xref>
###xml 412 416 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Koya1">[37]</xref>
###xml 578 582 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Farhangkhoee1">[41]</xref>
###xml 651 655 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Cosso1">[42]</xref>
###xml 742 746 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Avogaro1">[43]</xref>
###xml 747 751 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Song2">[45]</xref>
###xml 646 650 <span type="species:ncbi:10116">rats</span>
###xml 679 687 <span type="species:ncbi:9606">patients</span>
Data describing effect of diabetes on HO-1 expression are, however, conflicting. It has been demonstrated, especially in chemically induced diabetes in alloxan- or streptozotocin-injected animals, that HO-1 is upregulated in different cell types, soon after induction of hyperglycemia [36]-[40]. This was possibly associated with increased oxidative stress, as HO-1 upregulation could be reduced by antioxidants [37]. However, it has been suggested that diabetes-induced oxidative stress is, in part, due to pro-oxidant activity of HO-1, mediated by increased redox-active iron [41]. Induction of HO-1 was also reported in spontaneously diabetic rats [42] and in type 2 diabetic patients, especially those with nephropathy or atherosclerosis [43]-[45].
###end p 65
###begin p 66
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Rossi1">[46]</xref>
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-DiFilippo1">[35]</xref>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Quan1">[47]</xref>
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Sambuceti1">[49]</xref>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Moreira1">[50]</xref>
###xml 413 417 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-DaSilva1">[51]</xref>
###xml 430 434 430 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Adaikalakoteswari1">[52]</xref>
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Bruce1">[53]</xref>
###xml 250 254 <span type="species:ncbi:10116">rats</span>
###xml 289 293 <span type="species:ncbi:10116">rats</span>
###xml 374 382 <span type="species:ncbi:9606">patients</span>
On the contrary, there are many reports demonstrating downregulation of HO-1 expression in diabetes. Thus, the impaired levels of HO-1 were found within the ciliary bodies [46], cardiac tissue [35] or aortas [47]-[49] of streptozotocin-hyperglycemic rats and in the brain of Goto-Kakizaki rats [50]. Reduced basal expression of HO-1 was also demonstrated in type 2 diabetes patients in retinal pigment epithelium [51], leukocytes [52], and skeletal muscles [53].
###end p 66
###begin p 67
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Quan1">[47]</xref>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Sambuceti1">[49]</xref>
###xml 470 474 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-DiFilippo1">[35]</xref>
###xml 596 600 596 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Quan1">[47]</xref>
###xml 736 740 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Calabrese1">[44]</xref>
###xml 742 746 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Abraham1">[48]</xref>
###xml 255 259 <span type="species:ncbi:10116">rats</span>
###xml 701 709 <span type="species:ncbi:9606">patients</span>
Experiments carried out in animals treated with HO-1 inducers or inhibitors suggest that HO-1 may play a beneficial role in diabetes, attenuating the hyperglycemia-related complications. Thus, pharmacological activation of HO-1 in streptozotocin-injected rats led to protection of endothelial cells [47], restoration of normal rates of endothelial progenitor cell recruitment [49], and decreased production of proinflammatory cytokines after ischemia reperfusion stress [35]. This could be associated with higher concentration of serum bilirubin and reduced production of reactive oxygen species [47]. Similar finding, namely decreased oxidant production and oxidative-mediated injury was reported in patients with high HO-1 expression [44], [48].
###end p 67
###begin p 68
###xml 413 415 413 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 609 613 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Zhang1">[54]</xref>
###xml 842 844 842 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 1043 1045 1043 1045 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 985 988 <span type="species:ncbi:10116">rat</span>
###xml 1268 1276 <span type="species:ncbi:9606">patients</span>
Our data indicate for the first time that local delivery of HO-1 transgene by means of adenoviral vectors was sufficient to improve healing of excisional wounds in diabetic db/db mice, despite a low transduction efficacy. Unfortunately, we were unable to detect a difference in concentration of HO-1 protein in lysates of injured tissues between animals treated with therapeutic HO-1 or control GFP cDNAs on the 3rd day after gene transfer. Possibly the expression of transgene was masked by induction of endogenous HO-1, induced by wounding, inflammatory response to adenoviral vectors and by GFP expression [54]. The ELISA assay used for measuring the HO-1 protein in tissue lysates appears to be not sensitive enough to detect a subtle difference. We demonstrated, however, that HO-1 level was sustained in AdHO-1 treated animals on day 14th, when endogenous HO-1 was already attenuated, which implies a successful gene delivery. Expression of GFP in control wounds and presence of rat HO-1 mRNA in AdHO-1 treated wounds, detected also on 3rd day, confirms that adenoviral gene transfer was effective. It seems, that even such local overexpression of HO-1 can still improve wound closure and vascularization. Thus, a similar strategy could be proposed for diabetic patients suffering from non-healing ulcers.
###end p 68
###begin p 69
###xml 386 390 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Ashcroft1">[55]</xref>
###xml 391 395 391 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Goren1">[57]</xref>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
###xml 1133 1137 <span type="species:ncbi:10090">mice</span>
There are several possible mechanisms underlying the influence of HO-1 on healing of wounds, since its products exert proangiogenic, anti-apoptotic, cytoprotective and anti-inflammatory effects. One potential pathway is an inhibition of production of inflammatory cytokines. This may facilitate the wound healing and increase the reepithelialization, as demonstrated in several reports [55]-[57]. In our model, however, the effect of HO-1 on inflammatory response is not so clear. Analysis of blood collected three days after wounding showed that concentrations of many cytokines or growth factors are higher in mice of normal level of HO-1, whereas HO-1 deficiency or inhibition results in decreased cytokine production. Such relation was observed for sCD40 antigen, IL-2, KC, IL-17, IFNgamma, and GM-CSF. One can suppose, that the differences observed do not result from a direct effect of HO-1 on cytokine expressions, but are rather the consequences of different rate of wound closure, where at the same time the progression of healing is delayed in animals of lower HO-1 activity. Experiments carried out in HO-1 overexpressing mice seem to confirm lack or relatively weak influence of HO-1 on the cytokine production in response to wounding, as level of cytokines at the wound site was more dependent on wounding phase that on HO-1 activity, while production of inflammatory cytokines in transgenic keratinocytes was similar to control cells (data not shown).
###end p 69
###begin p 70
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Hanselmann1">[18]</xref>
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Ojha1">[58]</xref>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Dulak2">[59]</xref>
###xml 433 437 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Almolki1">[60]</xref>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Wu1">[61]</xref>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Patil1">[26]</xref>
It has been also postulated that HO-1 is beneficial in wound healing, due to protection of cells from toxic effects of reactive oxygen species, which are intensively generated at the site of injury, especially during first two days, in the inflammatory phase [18], [58]. Such a protective effect of HO-1 was demonstrated in many models, including ischemia/reperfusion injury [59], cigarette smoke-induced airway mucus hypersecretion [60], nephropathy [61] or corneal inflammation [26].
###end p 70
###begin p 71
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Altavilla1">[62]</xref>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Theilla1">[64]</xref>
###xml 551 555 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Shukla1">[65]</xref>
Significance of reduction of oxidative stress is indicated by experiments and clinical trials in which antioxidants improved wound healing, leading to increased epithelial cell proliferation and augmented angiogenesis [62]-[64]. Role of HO-1 in wounded skin may be especially important, as in cutaneous wounds the expressions of other antioxidative enzymes such as superoxide dismutase, glutathione peroxidase, glutathione-S-transferase, or catalase, as well as concentrations of ascorbic acid, vitamin D, and glutathione were significantly decreased [65].
###end p 71
###begin p 72
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Loboda1">[24]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Jozkowicz2">[13]</xref>
###xml 407 411 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Deshane1">[17]</xref>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Deshane1">[17]</xref>
###xml 824 828 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-LiCalzi1">[66]</xref>
HO-1 may also directly influence keratinocytes, facilitating their migration, improving survival in a stressful conditions of oxidative stress or hypoxia and tending to augment their proliferation. Cytoprotective and anti-apoptotic effects of HO-1 is very well documented [24]. Similarly, the important role of HO-1 in migration has been already shown in endothelial cells [13], and endothelial progenitors [17]. It seems that pro-migratory effect HO-1 depends on CO-induced phosphorylation and activation of vasodilator-activated phosphoprotein (VASP), a cytoskeletal-associated protein involved in motility, which is a downstream target for SDF-1 or IL-8 [17]. Recent study on microvascular endothelial cells has revealed that CO might regulate VASP phosphorylation and vascular cell migration also in diabetic conditions [66]. Thus, it seems that HO-1 dependent increase in migration and/or survival of keratinocytes and fibroblasts might contribute to improved wound closure.
###end p 72
###begin p 73
###xml 228 231 228 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Bloch1">[5]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Rossiter1">[67]</xref>
###xml 388 391 388 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Dickens1">[7]</xref>
###xml 392 395 392 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Suh1">[9]</xref>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Deshane1">[17]</xref>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Galeano1">[68]</xref>
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Galeano2">[69]</xref>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Ebrahimian1">[70]</xref>
###xml 508 511 508 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Michaels1">[4]</xref>
###xml 553 557 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Zhao1">[71]</xref>
###xml 785 789 785 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Drukala1">[33]</xref>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 659 664 <span type="species:ncbi:9606">human</span>
One of the crucial processes influencing tissue regeneration is angiogenesis. Thus, disturbed blood vessel formation, for example in mice with inhibited VEGF production in epidermal keratinocytes leads to delay in wound closure [5], [67]. Several studies, including those performed in diabetic animals, have demonstrated the importance of neovascularization not only in excisional wounds [7]-[9], [17], [68], but also in burn injuries [69] or hind limb ischemia [70]. Thus, induction of angiogenesis by VEGF [4] or basic fibroblast growth factor (bFGF) [71] can be proposed as a therapeutic strategy improving wound healing. Importantly, induction of HO-1 in human keratinocytes upregulates their angiogenic potential and may restore the VEGF production impaired by high glucose level [33].
###end p 73
###begin p 74
###xml 344 348 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Dulak1">[11]</xref>
###xml 350 354 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Jozkowicz2">[13]</xref>
###xml 356 360 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Deshane1">[17]</xref>
###xml 362 366 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Loboda1">[24]</xref>
###xml 368 372 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Drukala1">[33]</xref>
###xml 427 431 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Suzuki1">[15]</xref>
###xml 459 463 456 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Sunamura1">[16]</xref>
###xml 407 410 <span type="species:ncbi:10116">rat</span>
HO-1 may augment tissue neovascularization through increased production and/or activity of proangiogenic mediators, such as VEGF, monocyte chemotactic protein-1 (MCP-1), transforming growth factor-1 (TGF-beta) or SDF-1, and decreased synthesis of anti-angiogenic agents, like soluble VEGF receptor 1 (sVEGFR1), soluble endoglin (sEng) or IL-10 [11], [13], [17], [24], [33]. Hence, HO-1 gene transfer to the rat ischemic muscle [15] or to pancreatic carcinoma [16] can improve angiogenesis.
###end p 74
###begin p 75
###xml 965 969 965 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Drukala1">[33]</xref>
###xml 1078 1085 1078 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005803-t001">Table 1</xref>
###xml 1501 1505 1501 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Jozkowicz4">[72]</xref>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 945 950 <span type="species:ncbi:9606">human</span>
###xml 989 993 <span type="species:ncbi:10090">mice</span>
As expected, we observed impaired vascularization both in HO-1 deficient mice and in db/db mice, in which induction of HO-1 upon injury was weaker. Importantly, HO-1 gene transfer, leading to faster wound closure, resulted also in significantly augmented neovascularization in diabetic animals. Similarly, overexpression of HO-1 in keratinocytes in transgenic animals was associated with increased number of blood vessels in injured tissue. This suggests that beneficial role of HO-1 in wound healing may result from its proangiogenic activity. We confirmed decreased level of VEGF in the blood of HO-1 deficient animals three days after wounding, and tendency for reduced VEGF production in the wounded skin. Additionally, overexpression of HO-1 in keratinocytes was associated with slight, but statistically significant increase in VEGF synthesis in hypoxia. Stimulatory effect of HO-1 was also reported for hypoxia-induced VEGF expression in human keratinocytes [33]. Interestingly, in mice injected with SnPPIX, we did not observe decreased expression of VEGF in the blood (Table 1). Moreover, there was no difference in expression of VEGF in wounded skin and in number of blood vessels (data not shown). This may suggest that many effects of SnPPIX are HO-1 independent and that inhibition of wound closure by SnPPIX and by HO-1 deficiency relies on distinct mechanisms. Similar observations were reported in studies on effects of pharmacological or genetic HO-1 inhibition in cancer progression [72].
###end p 75
###begin p 76
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Minuzzo1">[73]</xref>
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Honorati1">[74]</xref>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Singh1">[75]</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Moyer1">[76]</xref>
###xml 595 599 595 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Groves1">[77]</xref>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 725 729 <span type="species:ncbi:10090">mice</span>
We found the reduced concentration of soluble CD40 antigen and IL-17 in HO-1 deficient mice. Both proteins may stimulate angiogenesis [73], [74]. Similar decrease was observed for proangiogenic IL-2 and KC, the cytokines which can accelerate the wound healing process through stimulating the proliferation of dermal fibroblasts or through augmenting the maturation of granulose tissue, respectively [75], [76]. Finally low activity of HO-1 led to decreased level of GM-CSF, the proangiogenic growth factor which facilitates wound contraction and induces keratinocyte proliferation and migration [77]. One could suggest that reduction of those mediators might contribute to wound healing impairment observed in HO-1 deficient mice.
###end p 76
###begin p 77
###xml 267 274 267 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 292 299 292 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 405 413 <span type="species:ncbi:9606">patients</span>
In summary, our study indicates that activation of HO-1 accelerates wound healing in normoglycemic and diabetic mice, what can be associated with augmented angiogenesis, increased migratory capacities and improved survival of keratinocytes. Overexpression of HO-1 by in vivo gene transfer or ex vivo transduction of keratinocytes may be proposed as a strategy for improvement of wound healing in diabetic patients.
###end p 77
###begin title 78
Materials and Methods
###end title 78
###begin title 79
Ethics statement
###end title 79
###begin p 80
All animals were handled in strict accordance with good animal practice as defined by the relevant national and/or local animal welfare bodies, and all animal work was approved by the Local Ethical Committee for Animal Research at the Jagiellonian University.
###end p 80
###begin title 81
Reagents
###end title 81
###begin p 82
###xml 803 805 800 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sub>
###xml 53 58 <span type="species:ncbi:10090">Mouse</span>
###xml 125 130 <span type="species:ncbi:10090">mouse</span>
###xml 161 164 <span type="species:ncbi:10116">rat</span>
###xml 170 175 <span type="species:ncbi:10090">mouse</span>
###xml 229 235 <span type="species:ncbi:9986">Rabbit</span>
###xml 287 291 <span type="species:ncbi:9925">goat</span>
###xml 297 303 <span type="species:ncbi:9986">rabbit</span>
SnPPIX was from Frontier Scientific (Carnforth, UK); Mouse Cytokine Antibody Array kit from Ray-Biotech (Norcross, GA); Anti-mouse CD31 and rhodamine-conjugated rat anti-mouse antibodies from BD Biosciences (Franklin Lakes, NJ); Rabbit anti-HO-1 antibody from Stressgen (Ann Arbor, MI); goat anti-rabbit-HRP antibody from CellSignaling Technology (Danvers, MA); Dispase, trypsin-EDTA, glutamine, sodium pyruvate, nonessential amino acids, penicillin, streptomycin, beta-mercaptoethanol, DMEM, and FCS from Gibco (Carlsbad, CA); Epidermal Keratinocyte Medium from CELLnTEC (Bern, Switzerland); Kit for ASPAT measurement from Biomerieux (Marcy l'Etoile, France); ELISA for VEGF from R&D (Minneapolis, MN); QIAzol from Qiagen (Valencia, CA); Turbo DNA Free Kit from Ambion (Austin, TX); M-MLV and oligo(dT)15 primers from Promega (Madison, WI); DNAzyme-II DNA polymerase from Finnzymes (Espoo, Finland); Cell Proliferation Kit from Roche (Basel, Switzerland); Adeno-X Virus Production Kit, Adeno-X Virus Purification Kit, and Adeno-X rapid titer ELISA from Clontech (Mountain View, CA); All other reagents were from Sigma-Aldrich (St. Louis, MO). All materials were approved for investigational-use only.
###end p 82
###begin title 83
Cell culture
###end title 83
###begin p 84
###xml 26 31 <span type="species:ncbi:9606">human</span>
HaCaT cells (immortalised human keratinocytes), kindly provided by Dr. Robert Fusening (Heidelberg University, Germany), were grown in DMEM medium, supplemented with FBS (10%), penicillin (100 U/ml) and streptomycin (10 microg/ml).
###end p 84
###begin title 85
Isolation and culture of primary keratinocytes
###end title 85
###begin p 86
###xml 363 364 359 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Skins were excised from 1-5-day old pups, purified of fat, washed in PBS with penicillin (100 U/ml) and streptomycin (100 microg/ml), and incubated overnight with dispase (6 U/ml). Epidermis was removed with forceps, placed in 0.05% trypsin-EDTA solution for a few minutes, and neutralized using complete DMEM with 10% FCS. Cell suspension was centrifuged at 200 g for 5 minutes at room temperature. The isolated keratinocytes were cultured in serum free CnT-07 PCT Epidermal Keratinocyte Medium.
###end p 86
###begin title 87
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 23 26 <span type="species:ncbi:10116">rat</span>
Detection of human and rat HO-1 mRNA in the skin
###end title 87
###begin p 88
###xml 105 107 105 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 260 287 260 287 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGAGGTCATCCCCTACACACC-3&#8242;</named-content>
###xml 292 318 292 318 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTGGGAGCGGGTGTTGAGTG-3&#8242;</named-content>
###xml 352 379 352 379 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GACATCACCAAGGGTGTGCAG-3&#8242;</named-content>
###xml 384 411 384 411 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCAGCACACTGGCATAGAGGC-3&#8242;</named-content>
###xml 446 475 446 475 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGAGTCCCTCACAGACAGAGTTT-3&#8242;</named-content>
###xml 480 509 480 509 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTGCAGAGAGAAGGCTACATGA-3&#8242;</named-content>
###xml 532 560 532 560 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTTTCAGAAGGGYCAGGTGWCC-3&#8242;</named-content>
###xml 565 593 565 593 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTGGAGMCGCTTYACRTAGYGC-3&#8242;</named-content>
###xml 627 653 627 653 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GACATCACCAAGGGTGTGCAG-3&#8242;</named-content>
###xml 658 685 658 685 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCAGCACACTGGCATAGAGGC-3&#8242;</named-content>
###xml 245 250 <span type="species:ncbi:9606">human</span>
###xml 338 343 <span type="species:ncbi:9606">human</span>
###xml 433 436 <span type="species:ncbi:10116">rat</span>
###xml 512 518 <span type="species:ncbi:10090">murine</span>
###xml 519 522 <span type="species:ncbi:10116">rat</span>
###xml 612 618 <span type="species:ncbi:10090">murine</span>
###xml 973 979 <span type="species:ncbi:10090">murine</span>
###xml 980 983 <span type="species:ncbi:10116">rat</span>
###xml 1009 1012 <span type="species:ncbi:10116">rat</span>
RNA was extracted from homogenized healthy or wounded skins using QIAzol and purified with Turbo DNA FreeTM kit. Two micrograms of total RNA was used for reverse transcription with M-MLV and oligo(dT) primers. PCR was performed with primers for human HO-1 (F: 5'-GGAGGTCATCCCCTACACACC-3'; R: 5'-CTGGGAGCGGGTGTTGAGTG-3'), and constitutive human EF2 (F: 5'-GACATCACCAAGGGTGTGCAG-3'; R: 5'-TCAGCACACTGGCATAGAGGC-3') or with primers for rat HO-1 (F: 5'-AGAGTCCCTCACAGACAGAGTTT-3'; R: 5'-CCTGCAGAGAGAAGGCTACATGA-3'), murine/rat HO-1 (F: 5'-CTTTCAGAAGGGYCAGGTGWCC-3'; R: 5'-GTGGAGMCGCTTYACRTAGYGC-3') and constitutive murine EF2 (F: 5'GACATCACCAAGGGTGTGCAG-3'; R: 5'-TCAGCACACTGGCATAGAGGC-3'). Real-time PCR reaction was done in cycles: 95degreesC for 30 s, 60degreesC for 60 s, 72degreesC for 45 s; data were analyzed with DeltaCt method. In regular PCR the reaction was done in cycles: 95degreesC for 45 s, 60degreesC for 30 s, 72degreesC for 60 s. We did 25 cycles for total (murine/rat) HO-1, and 35 cycles for rat HO-1.
###end p 88
###begin title 89
Cell proliferation assay
###end title 89
###begin p 90
Spontaneous cell proliferation was assessed by BrdU incorporation colorimetric assay performed according to the manufacturer's protocol. Cells (5,000 per well) were seeded in 96-well plate and assayed 48 h later.
###end p 90
###begin title 91
Migration assay
###end title 91
###begin p 92
Cells were grown to full confluence and treated with 10 mM hydroxyurea to block proliferation. A scratch was generated with a pipette tip. Photographs were taken at different time points, always from the same place, and analyzed using ImageJ programme (National Institute of Health, ).
###end p 92
###begin title 93
MTT reduction assay
###end title 93
###begin p 94
Thiazolyl blue tetrazolium bromide solution was added to the cells (0.5 mg/ml) for 0.5-1 h. Then, medium was removed and 100 microl of 2-propanol with 5 mM HCl were added to dissolve the formazan crystals. Optical density was measured at 560 nm.
###end p 94
###begin title 95
Preparation of adenoviral vectors
###end title 95
###begin p 96
###xml 30 33 <span type="species:ncbi:10116">rat</span>
Adenoviral vectors containing rat HO-1 cDNA (Ad-HO1) were kindly gifted by Dr. Gisa Tiegs (Erlangen, Germany). Control vectors harboring GFP cDNA (Ad-GFP) were produced using the Adeno-X system. Both vectors were propagated in 293 cells, purified using Adeno-X Virus Purification kit, and titrated with Adeno-X rapid titer ELISA kit.
###end p 96
###begin title 97
Animals and wound healing model
###end title 97
###begin p 98
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were anesthetized with isoflurane, wiped with 70% ethanol and shaved. Once the skin was exposed, two full-thickness (including panniculus carnosus) circular wounds (4 mm in diameter) on each animal were created using disposable biopsy punch. Each wound was photographed every day and analyzed using ImageJ software. For biochemical or immunohistochemical analysis wounded skin, together with a margin of healthy skin, was excised using 8 mm-diameter biopsy punch.
###end p 98
###begin title 99
Injection with SnPPIX
###end title 99
###begin p 100
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Immediately after wounding, mice (C57Bl/6, 3-month old) were divided into four groups and injected daily either intraperitoneally or subcutaneously with SnPPIX (45 micromol/kg of body weight, dissolved in 0.2 M NaOH), or with a vehicle (0.2 M NaOH in PBS).
###end p 100
###begin title 101
Adenoviral-mediated HO-1 gene transfer
###end title 101
###begin p 102
###xml 136 137 132 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 161 166 <span type="species:ncbi:10090">mouse</span>
Mice (db/db, 3-month old) were injured and injected intracutaneously at 3 points near the wound with AdGFP or AdHO-1 (100 microl, 2.3x108 IU/ml per wound). Each mouse received the same vector/vehicle in both wounds to avoid possible effects from leakage.
###end p 102
###begin title 103
###xml 26 30 <span type="species:ncbi:10090">mice</span>
HO-1 induction in skin in mice after injection with hemin
###end title 103
###begin p 104
###xml 32 36 <span type="species:ncbi:10090">mice</span>
C57BL wild type and C57BL db/db mice were injected intradermally with hemin (10 mg/kg of body weight). Animals were sacrificed after 24 hours and HO-1 expression was determined by immunoblotting.
###end p 104
###begin title 105
Protein isolation and western blotting
###end title 105
###begin p 106
###xml 368 372 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005803-Jozkowicz2">[13]</xref>
Skin was homogenized, lysed in 200 microl of ice-cold lysis buffer (PBS with 1% Triton X-100, 0.1 microg/ml PMSF, 1 microg/ml leupeptin and 1 microg/ml aprotinin), incubated on ice for 30 minutes, and centrifuged at 10,000 rpm at 4degreesC for 10 min. Supernatants were stored at -80degreesC. Samples were subjected to SDS-PAGE and immunoblotting as described earlier [13].
###end p 106
###begin title 107
CD31 staining
###end title 107
###begin p 108
###xml 104 108 <span type="species:ncbi:9925">goat</span>
###xml 164 167 <span type="species:ncbi:10116">rat</span>
###xml 173 178 <span type="species:ncbi:10090">mouse</span>
The wounds were cut into 8 microm slides. Cryosections were dried and blocked for at least 1 h with 10% goat serum, 0.05% Tween and 0.1% Triton x100 in PBS. Either rat anti-mouse CD31 or isotypic antibodies 1:100 in 10x diluted blocking buffer were applied for 1.5 h and then sections were washed with PBS. Secondary antibodies conjugated with rhodamine 1:1000 in PBS were applied for 0.5 h and the sections were washed with PBS. Slides were analyzed under the fluorescent microscope. Capillaries were counted in panniculus carnosus layer, in the direct vicinity of granulation tissue, at 400x magnification.
###end p 108
###begin title 109
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse cytokine antibody array
###end title 109
###begin p 110
###xml 57 62 <span type="species:ncbi:10090">Mouse</span>
Cytokines in blood serum were analyzed using Ray-Biotech Mouse Cytokine Antibody Array kit, according to vendor's protocol.
###end p 110
###begin title 111
Statistical analysis
###end title 111
###begin p 112
Statistical analysis was done using Student's t test or ANOVA followed by Tukey test. Data are presented as a mean+/-SD of 3-6 experiments.
###end p 112
###begin p 113
###xml 203 206 203 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
We are grateful to Aleksandra Sierpniowska, MVM, for her outstanding help during in vivo experiments. We also want to thank Dr. Anupam Agarwal, University of Alabama of Birmingham, for providing the HO-1-/- mice.
###end p 113
###begin title 114
References
###end title 114
###begin article-title 115
Wound repair and regeneration.
###end article-title 115
###begin article-title 116
Physiology and healing dynamics of chronic cutaneous wounds.
###end article-title 116
###begin article-title 117
Wound healing and its impairment in the diabetic foot.
###end article-title 117
###begin article-title 118
Topical vascular endothelial growth factor reverses delayed wound healing secondary to angiogenesis inhibitor administration.
###end article-title 118
###begin article-title 119
The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing.
###end article-title 119
###begin article-title 120
Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation.
###end article-title 120
###begin article-title 121
Regulable vascular endothelial growth factor165 overexpression by ex vivo expanded keratinocyte cultures promotes matrix formation, angiogenesis, and healing in porcine full-thickness wounds.
###end article-title 121
###begin article-title 122
Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells.
###end article-title 122
###begin article-title 123
Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization.
###end article-title 123
###begin article-title 124
The heme oxygenase system: a regulator of second messenger gases.
###end article-title 124
###begin article-title 125
Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells.
###end article-title 125
###begin article-title 126
Effect of prostaglandin-J(2) on VEGF synthesis depends on the induction of heme oxygenase-1.
###end article-title 126
###begin article-title 127
Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX.
###end article-title 127
###begin article-title 128
Role of heme oxygenase-1 in hydrogen peroxide-induced VEGF synthesis: effect of HO-1 knockout.
###end article-title 128
###begin article-title 129
###xml 72 75 <span type="species:ncbi:10116">rat</span>
Facilitated angiogenesis induced by heme oxygenase-1 gene transfer in a rat model of hindlimb ischemia.
###end article-title 129
###begin article-title 130
###xml 51 56 <span type="species:ncbi:9606">human</span>
Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer.
###end article-title 130
###begin article-title 131
Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism.
###end article-title 131
###begin article-title 132
Haem oxygenase-1: a novel player in cutaneous wound repair and psoriasis?
###end article-title 132
###begin article-title 133
Macrophage-derived heme-oxygenase-1: expression, regulation, and possible functions in skin repair.
###end article-title 133
###begin article-title 134
###xml 42 47 <span type="species:ncbi:9796">horse</span>
Heme oxygenase: protective gene or Trojan horse.
###end article-title 134
###begin article-title 135
Effects of protoporphyrins on production of nitric oxide and expression of vascular endothelial growth factor in vascular smooth muscle cells and macrophages.
###end article-title 135
###begin article-title 136
Pitfalls using metalloporphyrins in carbon monoxide research.
###end article-title 136
###begin article-title 137
Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications.
###end article-title 137
###begin article-title 138
: Heme Oxygenase-1 and the Vascular Bed: From Molecular Mechanisms to Therapeutic Opportunities.
###end article-title 138
###begin article-title 139
The heme-heme oxygenase system: a molecular switch in wound healing.
###end article-title 139
###begin article-title 140
Heme oxygenase-1 induction attenuates corneal inflammation and accelerates wound healing after epithelial injury.
###end article-title 140
###begin article-title 141
Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway.
###end article-title 141
###begin article-title 142
Heme oxygenase 1 is required for mammalian iron reutilization.
###end article-title 142
###begin article-title 143
###xml 62 66 <span type="species:ncbi:10090">mice</span>
MCP-1 is upregulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates.
###end article-title 143
###begin article-title 144
Reduced stress defense in heme oxygenase 1-deficient cells.
###end article-title 144
###begin article-title 145
###xml 33 41 <span type="species:ncbi:9606">patients</span>
Approach to skin ulcers in older patients.
###end article-title 145
###begin article-title 146
Anaemia in diabetes: an emerging complication of microvascular disease.
###end article-title 146
###begin article-title 147
###xml 14 19 <span type="species:ncbi:9606">human</span>
Locomotion of human skin keratinocytes on polystyrene, fibrin, and collagen substrata and its modification by cell-to-cell contacts.
###end article-title 147
###begin article-title 148
###xml 71 76 <span type="species:ncbi:9606">human</span>
Effect of heme oxygenase-1 on VEGF synthesis and angiogenic potency of human keratinocytes.
###end article-title 148
###begin article-title 149
###xml 49 52 <span type="species:ncbi:10116">rat</span>
Hyperglycemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial HO-1 during ischemia/reperfusion.
###end article-title 149
###begin article-title 150
###xml 66 70 <span type="species:ncbi:10116">rats</span>
Enhancement of glomerular heme oxygenase-1 expression in diabetic rats.
###end article-title 150
###begin article-title 151
###xml 90 94 <span type="species:ncbi:10116">rats</span>
Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats.
###end article-title 151
###begin article-title 152
Heme oxygenase in the retina in diabetes.
###end article-title 152
###begin article-title 153
###xml 121 125 <span type="species:ncbi:10090">mice</span>
Effect of Momordica grosvenori on oxidative stress pathways in renal mitochondria of normal and alloxan-induced diabetic mice. Involvement of heme oxygenase-1.
###end article-title 153
###begin article-title 154
###xml 94 97 <span type="species:ncbi:10116">rat</span>
Alpha-lipoic acid modulates heat shock factor-1 expression in streptozotocin-induced diabetic rat kidney.
###end article-title 154
###begin article-title 155
Heme oxygenase in diabetes-induced oxidative stress in the heart.
###end article-title 155
###begin article-title 156
###xml 65 69 <span type="species:ncbi:10116">rats</span>
Induction of heme oxygenase 1 in liver of spontaneously diabetic rats.
###end article-title 156
###begin article-title 157
###xml 122 130 <span type="species:ncbi:9606">patients</span>
Monocyte NADPH oxidase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress.
###end article-title 157
###begin article-title 158
Oxidative stress and cellular stress response in diabetic nephropathy.
###end article-title 158
###begin article-title 159
Overexpression of heme oxygenase-1 in coronary atherosclerosis of Japanese autopsies with diabetes mellitus: Hisayama study.
###end article-title 159
###begin article-title 160
Hyperglycemia in streptozotocin-induced diabetes leads to persistent inflammation and tissue damage following uveitis due to reduced levels of ciliary body heme oxygenase-1.
###end article-title 160
###begin article-title 161
###xml 93 97 <span type="species:ncbi:10116">rats</span>
Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats.
###end article-title 161
###begin article-title 162
###xml 18 23 <span type="species:ncbi:9606">human</span>
Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes.
###end article-title 162
###begin article-title 163
Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage; Reversed by increases in pAMPK, heme oxygenase-1 and adiponectin.
###end article-title 163
###begin article-title 164
###xml 164 168 <span type="species:ncbi:10116">rats</span>
Reduced HO-1 protein expression is associated with more severe neurodegeneration after transient ischemia induced by cortical compression in diabetic Goto-Kakizaki rats.
###end article-title 164
###begin article-title 165
Diminished heme oxygenase-1 mRNA expression in RPE cells from diabetic donors as quantitated by competitive RT/PCR.
###end article-title 165
###begin article-title 166
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Differential gene expression of NADPH oxidase (p22phox) and hemoxygenase-1 in patients with type 2 diabetes and microangiopathy.
###end article-title 166
###begin article-title 167
###xml 77 85 <span type="species:ncbi:9606">patients</span>
Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism.
###end article-title 167
###begin article-title 168
Green fluorescent protein selectively induces HSP70-mediated upregulation of COX-2 expression in endothelial cells.
###end article-title 168
###begin article-title 169
Androgen receptor-mediated inhibition of cutaneous wound healing.
###end article-title 169
###begin article-title 170
Androgens modulate the inflammatory response during acute wound healing.
###end article-title 170
###begin article-title 171
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages.
###end article-title 171
###begin article-title 172
Assessment of wound-site redox environment and the significance of Rac2 in cutaneous healing.
###end article-title 172
###begin article-title 173
Heme oxygenase-1 and carbon monoxide in vascular pathobiology. Focus on angiogenesis.
###end article-title 173
###begin article-title 174
###xml 96 102 <span type="species:ncbi:9606">humans</span>
Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans.
###end article-title 174
###begin article-title 175
###xml 40 46 <span type="species:ncbi:10090">murine</span>
HO-1 induction ameliorates experimental murine membranous nephropathy: anti-oxidative, anti-apoptotic and immunomodulatory effects.
###end article-title 175
###begin article-title 176
Lipid peroxidation by raxofelast improves angiogenesis and wound healing in experimental burn wounds.
###end article-title 176
###begin article-title 177
###xml 171 176 <span type="species:ncbi:10090">mouse</span>
Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse.
###end article-title 177
###begin article-title 178
###xml 146 154 <span type="species:ncbi:9606">patients</span>
A diet enriched in eicosapentanoic acid, gamma-linolenic acid and antioxidants in the prevention of new pressure ulcer formation incritically ill patients with acute lung injury: a randomize, prospective, controlled study.
###end article-title 178
###begin article-title 179
Depletion of reduced glutathione, ascorbic acid, vitamin E and antioxidant defence enzymes in a healing cutaneous wound.
###end article-title 179
###begin article-title 180
Carbon Monoxide and Nitric Oxide Mediate Cytoskeletal Reorganization in Microvascular Cells via Vasodilator-Stimulated Phosphoprotein (VASP) Phosphorylation: Evidence for Blunted Responsiveness in Diabetes.
###end article-title 180
###begin article-title 181
###xml 55 61 <span type="species:ncbi:10090">murine</span>
Loss of vascular endothelial growth factor activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation.
###end article-title 181
###begin article-title 182
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 164 169 <span type="species:ncbi:10090">mouse</span>
Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse.
###end article-title 182
###begin article-title 183
###xml 22 44 <span type="species:ncbi:272636">adeno-associated virus</span>
Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury.
###end article-title 183
###begin article-title 184
###xml 107 111 <span type="species:ncbi:10090">mice</span>
NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes.
###end article-title 184
###begin article-title 185
###xml 58 63 <span type="species:ncbi:9606">human</span>
Improved neovascularization and wound repair by targeting human basic fibroblast growth factor (bFGF) to fibrin.
###end article-title 185
###begin article-title 186
Heme oxygenase-1 in tumor: is it a false friend?
###end article-title 186
###begin article-title 187
Angiogenesis meets immunology: cytokine gene therapy of cancer.
###end article-title 187
###begin article-title 188
Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts.
###end article-title 188
###begin article-title 189
###xml 11 14 <span type="species:ncbi:10116">rat</span>
###xml 33 36 <span type="species:ncbi:10116">rat</span>
###xml 87 90 <span type="species:ncbi:10116">rat</span>
Effects of rat interleukin-2 and rat interferon on the natural killer cell activity of rat spleen cells after thermal injury.
###end article-title 189
###begin article-title 190
Effects of interleukin-8 on granulation tissue maturation.
###end article-title 190
###begin article-title 191
###xml 12 17 <span type="species:ncbi:9606">human</span>
Recombinant human GM-CSF in the treatment of poorly healing wounds.
###end article-title 191
###begin p 192
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 192
###begin p 193
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants no. 3156/P01/2007/32, 512/6 PR UE/2008/7, 347/N-INCA/2008/0, 106/P05/2004 and 2 P04 016 26 from Ministry of Science and Higher Education. AJ is a recipient of the Wellcome Trust Senior Research Fellowship in Basic Biomedical Science. HW is a fellow of Start program by Foundation for Polish Science. Department of Medical Biotechnology was a member of the European Vascular Genomics Network (grant No: LSHM-CT 2003-503254) and participates in the COST CM0602 Action (ANGIOKEM), both supported by European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 193

